Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  01:00 2022-11-25 pm EST
176.40 USD   -0.23%
05:26aInsider Sell: Moderna
MT
04:57aInsider Sell: Moderna
MT
11/24Researchers test mRNA technology for universal flu vaccine
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Insider Sell: Moderna

09/23/2022 | 04:52pm EST


ę MT Newswires 2022
All news about MODERNA, INC.
05:26aInsider Sell: Moderna
MT
04:57aInsider Sell: Moderna
MT
11/24Researchers test mRNA technology for universal flu vaccine
RE
11/23B.C. study finds low but increased risk of myocarditis after 2nd Moderna COVID shot
AQ
11/22US renews push for COVID boosters as data show they protect
AQ
11/22CDC Says Pfizer-BioNTech, Moderna New Boosters Better Than Older Formulation in COVID-1..
MT
11/22Updated COVID vaccines offer better protection than original -U.S. study
RE
11/22Fauci pleads with Americans to get COVID shot in final White House briefing
RE
11/21Insider Sell: Moderna
MT
11/18Insider Sell: Moderna
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 19 089 M - -
Net income 2022 8 897 M - -
Net cash 2022 12 022 M - -
P/E ratio 2022 8,18x
Yield 2022 -
Capitalization 67 769 M 67 769 M -
EV / Sales 2022 2,92x
EV / Sales 2023 6,16x
Nbr of Employees 2 700
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 176,40 $
Average target price 211,25 $
Spread / Average Target 19,8%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
James M. Mock Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-30.55%67 769
IQVIA HOLDINGS INC.-22.03%40 859
LONZA GROUP AG-33.93%39 445
ALNYLAM PHARMACEUTICALS, INC.25.44%26 171
SEAGEN INC.-20.16%22 918
CELLTRION, INC.-11.62%18 063